BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 395684)

  • 1. Survival of cardiac allografts in rats treated with cyclosporin A.
    Jamieson SW; Burton NA; Bieber CP; Reitz BA; Oyer PE; Stinson EB; Shumway NE
    Surg Forum; 1979; 30():289-91. PubMed ID: 395684
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporin-A-induced long-term survival of fully incompatible skin and heart grafts in rats.
    White DJ; Rolles K; Ottawa T; Turell O
    Transplant Proc; 1980 Jun; 12(2):261-5. PubMed ID: 6994294
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of cyclosporin A on experimental pancreas allografts in the rat.
    Garvey JF; McShane P; Poole MD; Millard PR; Morris PJ
    Transplant Proc; 1980 Jun; 12(2):266-9. PubMed ID: 6771902
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolongation of heterotopic cardiac allografts in rats by cyclosporin A.
    Kawahara K; Sutherland DE; Rynasiewicz JJ; Najarian JS
    Surgery; 1980 Oct; 88(4):594-600. PubMed ID: 6999652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrimental effect of steroids on cyclosporin-A-induced prolonged allograft survival.
    Dunn DC; White DJ; Herbertson BM; Rolles K
    Transplant Proc; 1980 Jun; 12(2):335-8. PubMed ID: 6994303
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolongation of canine pancreas allografts with cyclosporin A.
    McMaster P; Procyshyn A; Calne RY; Valdes R; Rolles K; Smith D
    Transplant Proc; 1980 Jun; 12(2):275-7. PubMed ID: 6771904
    [No Abstract]   [Full Text] [Related]  

  • 7. Mode of action of cyclosporin A: a new immunosuppressive agent.
    White DJ; Calne RY; Plumb A
    Transplant Proc; 1979 Mar; 11(1):855-9. PubMed ID: 377718
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of cardiac allograft prolongation by cyclosporin-A.
    Hutchinson IF; Shadur CA; Duarte A; Baldwin WM; Strom TB; Tilney NL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):412-3. PubMed ID: 6455797
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporin A prolongation of segmental pancreatic and islet allograft function in rats.
    Rynasiewicz JJ; Sutherland DE; Kawahara K; Gorecki P; Najarian JS
    Transplant Proc; 1980 Jun; 12(2):270-4. PubMed ID: 6771903
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased efficacy of cyclosporin A with splenectomy prolonging the survival of rat heart allografts.
    Downing TP; Reitz BA; Stinson EB; Aziz S; Shumway N
    Transplantation; 1981 Jul; 32(1):76-7. PubMed ID: 7022803
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolongation of allograft survival by cyclosporin A.
    Cosimi AB; Shield CF; Peters C; Burton RC; Scott G; Russell PS
    Surg Forum; 1979; 30():287-9. PubMed ID: 120019
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of various methods of chemical immunosuppression in islet cell transplantation.
    Bell PR; Wood RF; Peters M; Nash JR
    Transplant Proc; 1980 Jun; 12(2):291-3. PubMed ID: 6249004
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties of cyclosporin--A-induced graft acceptance.
    White DJ; Timmerman W; Davies HS; Nagao T; Kasahara K; Plumb A
    Transplant Proc; 1981 Mar; 13(1 Pt 1):379-82. PubMed ID: 7022857
    [No Abstract]   [Full Text] [Related]  

  • 14. Orthotopic heart and combined heart and lung transplantation with cyclosporin-A immune suppression.
    Reitz BA; Bieber CP; Raney AA; Pennock JL; Jamieson SW; Oyer PE; Stinson EB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):393-6. PubMed ID: 6791329
    [No Abstract]   [Full Text] [Related]  

  • 15. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
    Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K
    Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226
    [No Abstract]   [Full Text] [Related]  

  • 16. Orthotopic liver transplantation. Various immunosuppressive regimens to improve survival.
    Toledo-Pereyra LH; Bandlien KO; MacKenzie GH; Gordon DA
    Am Surg; 1984 May; 50(5):258-63. PubMed ID: 6372562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total lymphoid irradiation in rat heart allografts: dose, fractionation, and combination with cyclosporin-A.
    Rynasiewicz JJ; Sutherland DE; Kawahara K; Kim T; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):452-4. PubMed ID: 7022872
    [No Abstract]   [Full Text] [Related]  

  • 18. Donor pretreatment in cardiac allografts.
    Nowygrod R; Hardy MA; Todd GJ; Oluwole S; Reemtsma K
    Transplant Proc; 1979 Jun; 11(2):1462-4. PubMed ID: 382540
    [No Abstract]   [Full Text] [Related]  

  • 19. Rejection of long-surviving mouse skin allografts after withdrawal of cyclosporin A therapy.
    Lems SP; Capel PJ; Koene RA
    Transplant Proc; 1980 Jun; 12(2):283-6. PubMed ID: 6994296
    [No Abstract]   [Full Text] [Related]  

  • 20. Didemnin B prolongs rat heart allograft survival.
    Stevens DW; Jensen RM; Stevens LE
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1139-40. PubMed ID: 2650080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.